Artios Pharma, a U.K. based company in Cambridge, has raised $84 million to take DNA damage response (DDR) programs to the next level of clinical proof of concept.
A massive new study led by scientists at the University of Liverpool, UCL, Johns Hopkins Bloomberg School of Public Health and partners in Malawi has become the foremost to offer population-level substantiation from a low-income country that rotavirus vaccination decreased diarrhea deaths in infants by 34%.
Findings from a study conducted by Prof. Marco Falasca from Queen Mary University of London (QMUL) in the United Kingdom and team on a mouse model of pancreatic cancer, which they injected with cannabidiol (CBD), naturally occurring cannabis along with a classic chemotherapy drug, Gemcitabine, revealed that the rodents lived almost three times more than mice from a control group, which had been treated with Gemcitabine only.
HOWELL HE-607A is a surgical table designed for otolaryngology and ophthalmic surgery. This operation table meets clinical demands, is stable, durable and convenient, with minimal noise.
A European Radiology Experimental journal article describes how a team of researchers have established and validated an augmented reality system that could enable high accuracy interventional cancer treatments.
HitGen and Merck have updated their licensing agreement to a full-fledged drug discovery collaboration in order to screen DNA-encoded libraries for new small-molecule assets.
As one of the biggest generic drug manufacturing countries in the world, India’s pharmaceutical industry has increased by 13% - 14% within the last 5 years. As a result, many companies are looking to take advantage of this growth but are in need of guidance.
GE Healthcare has launched a second phase III (AURORA) clinical trial for using Flurpiridaz 18F Injection in positron-emission tomography (PET) myocardial perfusion imaging (MPI), in order to detect coronary artery disease (CAD).
New sponsor OCA Ventures along with existing financiers have granted $1 million in Series A funding to PatientWisdom, a digital health corporation working on real-world data compilation tools. The company’s total funding is now worth $3.45 million.
Clinical Innovations has launched its new subsidiary in Shanghai to grow in the Chinese labor and delivery market, expanding its global footprint.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.